 |
 Video: What is a Stock Split?
|
|
|
| Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the following main areas: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; Surgical Structural Heart, which is engaged in cardiac surgical therapies; and Critical Care, which is engaged in hemodynamic monitoring systems. According to our EW split history records, Edwards Lifesciences has had 4 splits. | |
|
Edwards Lifesciences (EW) has 4 splits in our EW split history database. The first split for EW took place on May 27, 2010. EW's second split took place on May 28, 2010. This was a 2 for 1 split, meaning for each share of EW owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. EW's third split took place on December 14, 2015. This was a 2 for 1 split, meaning for each share of EW owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. EW's 4th split took place on June 01, 2020. This was a 3 for 1 split, meaning for each share of EW owned pre-split, the shareholder now owned 3 shares. For example, a 4000 share position pre-split, became a 12000 share position following the split.
When a company such as Edwards Lifesciences splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the EW split history from start to finish, an original position size of 1000 shares would have turned into 12000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Edwards Lifesciences shares, starting with a $10,000 purchase of EW, presented on a split-history-adjusted basis factoring in the complete EW split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/07/2014 |
|
| End date: |
10/03/2024 |
|
| Start price/share: |
$17.67 |
|
| End price/share: |
$65.37 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
269.95% |
|
| Average Annual Total Return: |
13.98% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$36,993.96 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 05/27/2010 | 1 for 1 | | 05/28/2010 | 2 for 1 | | 12/14/2015 | 2 for 1 | | 06/01/2020 | 3 for 1 |
|
|
Free EW Email Alerts:
